Analyst Consensus
- Current Price
- 1,050.09 $
- Target (Low)
- 1,140.00 $
- Target (Mean)
- 1,246.25 $
- Target (High)
- 1,393.00 $
- Recommendation
- Buy
- Number of Analysts
- 16
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 10 |
|---|
| Hold | 3 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 24.4%
- Operating Margin
- 35.6%
- Gross Margin
- 46.9%
- Return on Equity (ROE)
- 11.9%
- Return on Assets (ROA)
- 3.6%
- Revenue Growth
- 27.0%
- Earnings Growth
- 45.9%
- Debt/Equity
- 23.64
- Current Ratio
- 2.17
- Beta
- 1.43
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Apr 15, 2026 | UBS | Buy → Buy |
| Apr 15, 2026 | Morgan Stanley | Overweight → Overweight |
| Apr 15, 2026 | Goldman Sachs | Buy → Buy |
| Apr 15, 2026 | Evercore ISI Group | Outperform → Outperform |
| Apr 15, 2026 | Barclays | Overweight → Overweight |
| Apr 15, 2026 | Keefe, Bruyette & Woods | Outperform → Outperform |